1. Agid, Y., Javoy-Agid, F., and Ruberg, M., 1992, Biochemistry of Neurotransmitters in Parkinson’s Disease, in: Movement Disorders 2, C.D. Marsden and S. Fahn, eds. Butterworths„ pp. 166–230.
2. Alderson, R. F, Alterman, A.., Morissey, D., and Lindsay, R. M., 1993, Effects of NT-4/5, BDNF, or NGF on the survival and phenotypic differentiation of septal cholinergic neurons in long-term cultures, Soc. Neurosci. Abstr. 19: 666.
3. Altar, C. A., Boylan, C. B., Jackson, C., Hershenson, S., Miller, J., Wiegand, S.J., Lindsay, R. M., and Hyman, C., 1992, Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo, Proc. Natl. Acad. Sci. (USA) 89: 11347–11351.
4. Altar, C. A., Criden, M. R., Lindsay, R. M., and DiStefano, P. S., 1993, Characterization and topography of high affinity VI]neurotrophin-3 binding to mammalian brain, J. Neurosci. 13: 733–743.
5. Altar, C.A., Siuciak, J., Boylan, C., Fritsche, M., Wiegand, S. J., Alderson, R.F. and Lindsay, R.M., 1993b, Effects of BDNF and NT-3 on serotonin, dopamine, and acetylcholine neurons in vivo, J. Neurochem. 61 ( Suppl. ): S7C.